As clinical trials for cell and gene therapies continue to show promise, the cell therapy community is dedicating more attention toward identifying innovative cell manufacturing technologies that can maintain product efficacy, decrease production time, and scale supply to meet commercial demand. This entails determining stages of the production workflow where optimization is necessary, qualifying new technologies that improve that stage of the workflow, and establishing supplier relationships to secure raw materials for scale-up. During this session we will introduce Bio-Techne as an innovative solutions provider for regulatory-compliant raw materials and instrumentation across the ex vivo manufacturing workflow for stem cell and immune cell therapies.

The session will focus on:

• Manufacturing process optimization during ex vivo expansion
• Novel tools for cell culture optimization and cell characterization
• Considerations for raw material sourcing, including GMP small molecules and proteins.

SPEAKERS

		Scott Schachtele, Ph.D. Product Manager, Cell Culture and Regenerative Medicine Bio-Techne
Scott Schachtele is a Product Manager for the Cell Culture and Regenerative Medicine portfolio at Bio-Techne. Scott works closely with the research teams at Bio-Techne and with industry partners to develop and offer innovative solutions that support cell, gene, and regenerative therapy manufacturing. Scott received his Ph.D. in Neuroscience and joined Bio-Techne in 2014.